Norfolk Southern Corp. (NSC) Financials Nov 17, 2014, 6:03
Norfolk Southern Corp. (NSC) Financials Nov 17, 2014, 6:03 p.m.
Income Statement Balance Sheet Cash Flow Statement
Annual Financials for Norfolk Southern Corp.
Fiscal year is January-December. All values USD millions. 2009 2010 2011 2012 2013 5-year trend
Sales/Revenue 7.97B 9.52B 11.17B 11.04B 11.25B
Cost of Goods Sold (COGS) incl. D&A 6.01B 6.85B 7.97B 7.92B 7.99B
COGS excluding D&A 5.17B 6.02B 7.1B 7B 7.07B
Depreciation & Amortization Expense 837M 826M 869M 922M 922M
Depreciation 837M 826M 869M 922M 922M
Amortization of Intangibles 0 0 0 0 0
Gross Income 1.96B 2.67B 3.21B 3.12B 3.25B
2009 2010 2011 2012 2013 5-year trend
SG&A Expense 0 0 0 0 0
Research & Development 0 0 0 0 0
Other SG&A 0 0 0 0 0
Other Operating Expense 0 0 0 0 0
Unusual Expense 0 0 0 0 0
EBIT after Unusual Expense 0 0 0 0 0
Non Operating Income/Expense 87M 138M 127M 93M 201M
Non-Operating Interest Income 13M 12M 9M 8M 8M
Equity in Affiliates (Pretax) 32M 26M 31M 34M 42M
Interest Expense 472M 478M 455M 495M 537M
Gross Interest Expense 489M 493M 474M 515M 555M
Interest Capitalized 17M 15M 19M 20M 18M
Pretax Income 1.62B 2.37B 2.92B 2.76B 2.97B
Income Tax 588M 871M 1B 1.01B 1.06B
Income Tax - Current Domestic 250M 559M 475M 643M 793M
Income Tax - Current Foreign - - - - -
Income Tax - Deferred Domestic 338M 312M 527M 366M 262M
Income Tax - Deferred Foreign - - - - -
Income Tax Credits 0 0 0 0 0
Equity in Affiliates 0 0 0 0 0
Other After Tax Income (Expense) (8M) (8M) (9M) (9M) (7M)
Consolidated Net Income 1.03B 1.49B 1.91B 1.74B 1.9B
Minority Interest Expense 0 0 0 0 0
Net Income 1.03B 1.49B 1.91B 1.74B 1.9B
Extraordinaries & Discontinued Operations 0 0 0 0 0
Extra Items & Gain/Loss Sale Of Assets 0 0 0 0 0
Cumulative Effect - Accounting Chg 0 0 0 0 0
Discontinued Operations 0 0 0 0 0
Net Income After Extraordinaries 1.03B 1.49B 1.91B 1.74B 1.9B
Preferred Dividends 0 0 0 0 0
Net Income Available to Common 1.03B 1.49B 1.91B 1.74B 1.9B
EPS (Basic) 2.79 4.06 5.52 5.42 6.10
Basic Shares Outstanding 367.1M 366.5M 345.5M 320.9M 311.9M
EPS (Diluted) 2.76 4.00 5.45 5.37 6.04
Diluted Shares Outstanding 372.1M 371.8M 351.3M 325.2M 315.5M
EBITDA 2.8B 3.5B 4.08B 4.04B 4.17B
Copyright 2014 FactSet Research Systems Inc. All rights reserved. Source FactSet Fundamentals.
Scroll down for more posts ▼
Top 10 Most Recent News Articles
Stepping into the chaos of the stock market sometimes feels like opening Pandora's box—just when you think you've seen it all, something new tumbles out. This time around, it's Honeywell Aerospace (NasdaqGS: HONA) playing catch with hot coals, and a burning class-action lawsuit smolders in the air. Deadline Looms for Investors in Class Action Heads up, folks! If you've...
Continue Reading
Forecasts and Fierce Digital Landscapes Just when you thought the online trading realm was getting saturated, the numbers are making it clear: there’s still room for growth—even explosive growth. The online trading platform market is eyeing a hike, jumping from a $11.65 billion valuation in 2025 to a projected $18.18 billion by 2031, according to Mordor Intelligence....
Continue Reading
Kal Plastics Steps into the Limelight There's a buzz in the air, and it's all about Kal Plastics getting ready to strut their stuff at the Southern California Design-2-Part Show. Now, most folks probably don't spend their nights dreaming about thermoforming and pressure forming, but these guys sure make a case for it. They’ve got their eyes on impressing the crowd with...
Continue Reading
Unpacking Aetna's Medicare Strategy for 2027 Look, if there's one thing you should keep tabs on, it's how Aetna isn't just coasting by in the healthcare arena. These folks are pushing forward with new options for 2027 that prove they're serious about making healthcare not just accessible, but affordable across the board. Aetna, backed by CVS Health (NYSE: CVS), is making...
Continue Reading
Lighting Up Halloween the Hollywood Way When it comes to Halloween, folks go nuts driving up the thrill factor at home, and boy, has Govee nailed it this time around. They've dragged Sarah Michelle Gellar into their spooky mix, transforming homes into eerie masterpieces. And let's face it, who better than the 'Buffy the Vampire Slayer' herself to stir those spine-tingling...
Continue Reading
Sea Rise Isn’t Just a Statistics Problem The ordeal of rising seas isn't just about staring at numbers in some spreadsheet, it's a real-world gut punch that's knocking at Venice's door. This city, known for its stunning architecture and winding canals, now serves as the poster child for what happens when Mother Nature and human errors leave a place on the brink of...
Continue Reading
Ractigen's New Fight Against Duchenne: A Personal Take When it comes to biotech advancements, I've seen enough breakthroughs to not get swayed easily. But Ractigen Therapeutics presenting their first-in-human data on RNA activation for Duchenne Muscular Dystrophy (DMD) kind of demands your attention. Folks, they're talking about a potential shift in handling this brutal...
Continue Reading
Uncovering the Truth Behind Cabinet Decisions When it comes to sprucing up a kitchen, most folks overlook what's hanging on their walls already: those tired old cabinets. Now, are you looking at chucking them out the window for brand-new ones, or can a fresh coat of paint breathe new life into them? Well, that's where Melvin Jones, a painting virtuoso from Lexington,...
Continue Reading
The humdrum world of golf carts just got a jolt of energy with lithium batteries entering the fray. Vatrer Power, the brain behind some nifty LiFePO4 lithium battery conversions, made some noise at this year's Golf Carting Expo & Dealer Summit in Charleston, South Carolina. Held at the North Charleston Convention Center, this trade show was the industry's premier...
Continue Reading
Top 5 Most Recently Viewed Articles
Virbac's Impressive Growth in Early 2025 In an exciting development for Virbac, the company has announced a remarkable revenue growth of +5.6% for the first half of 2025, adjusted for constant exchange rates and considering its consolidation scope. This growth speaks volumes about the ability of Virbac to adapt and thrive in a competitive animal health market. Key...
Continue Reading
Amprius Technologies Ships Advanced EV Cells Amprius Technologies, Inc. (NYSE: AMPX), a pioneer in high-performance lithium-ion batteries, has made a significant advancement by delivering its SiMaxx™ A-Sample EV Cells to a prominent consortium that focuses on developing cutting-edge battery technologies. This collaboration aims to address crucial performance and cost...
Continue Reading
Jyske Bank A/S Completes Significant Bond Offering Jyske Bank A/S has successfully concluded a substantial bond offering, demonstrating confidence in its financial health and the stability of the market. This bond issuance, involving a total of 750 million euros, was categorized as a EUR 6.25NC5.25 Reg S Eurobond. Notably, it has been officially listed on the Dublin stock...
Continue Reading
Nitrado's Rise in Game Server Hosting Nitrado has gained significant recognition in recent times as a provider of game server hosting, particularly in its ability to cater to a variety of online multiplayer games. As renovations within the gaming industry continue, the need for dependable hosting solutions has escalated. Players want uninterrupted gameplay, enhanced...
Continue Reading
Windtree Therapeutics Inc. Celebrates Stockholder Approvals Windtree Therapeutics Inc. (NASDAQ: WINT), a notable biotechnology company focused on innovative biological solutions, is excited to share the successful outcomes from its Annual Meeting of Stockholders. This important meeting, which took place online, showcased the commitment and support of its dedicated...
Continue Reading